Gambaran Umum
Syngene International Limited is a leading contract research organization based in India. Operating in the biopharmaceutical industry, the company offers integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, antibody-drug conjugates, and oligonucleotides. Key projects include strategic partnerships with global pharma companies like Bristol-Myers Squibb and Amgen for dedicated research centers. Syngene also has collaborations with academia and industry in areas like infectious diseases and immuno-oncology. The company's comprehensive services span early-stage discovery, process development, cGMP manufacturing, and formulation development, making it a preferred partner for many global pharmaceutical firms.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Biocon Limited per 2025 Jun 30 adalah 157,707.00 MM.
- Nilai operating income untuk Biocon Limited per 2025 Jun 30 adalah 16,220.00 MM.
- Nilai net income untuk Biocon Limited per 2025 Jun 30 adalah 3,850.00 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 157,707.00 | 16,220.00 | 3,850.00 |
2025-03-31 | 152,617.00 | 15,431.00 | 10,133.00 |
2024-12-31 | 147,618.00 | 13,998.00 | 8,043.00 |
2024-09-30 | 148,941.00 | 15,857.00 | 14,392.00 |
2024-06-30 | 147,660.00 | 16,420.00 | 15,808.00 |
2024-03-31 | 147,557.00 | 17,834.00 | 10,225.00 |
2023-12-31 | 146,125.00 | 20,203.00 | 12,002.00 |
2023-09-30 | 135,999.00 | 18,512.00 | 4,984.00 |
2023-06-30 | 124,573.00 | 17,388.00 | 4,197.00 |
2023-03-31 | 111,742.00 | 15,643.00 | 4,627.00 |
2022-12-31 | 98,091.00 | 11,470.00 | 3,881.00 |
2022-09-30 | 90,422.00 | 11,413.00 | 6,170.00 |
2022-06-30 | 85,629.00 | 11,457.00 | 7,084.00 |
2022-03-31 | 81,840.00 | 11,583.00 | 6,484.00 |
2021-12-31 | 75,800.00 | 10,507.00 | 6,630.00 |
2021-09-30 | 72,632.00 | 9,323.00 | 6,445.00 |
2021-06-30 | 71,726.00 | 9,017.00 | 6,755.00 |
2021-03-31 | 71,431.00 | 9,539.00 | 7,405.00 |
2020-12-31 | 68,913.00 | 8,463.00 | 6,107.00 |
2020-09-30 | 67,571.00 | 9,277.00 | 6,449.00 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 6.72 | 6.71 |
2024-09-30 | 12.03 | 12.00 |
2024-06-30 | 13.21 | 13.19 |
2024-03-31 | 8.55 | 8.54 |
2023-12-31 | 10.06 | 10.03 |
2023-09-30 | 4.18 | 4.17 |
2023-06-30 | 3.52 | 3.51 |
2023-03-31 | 3.88 | 3.87 |
2022-12-31 | 3.25 | 3.24 |
2022-09-30 | 5.17 | 5.16 |
2022-06-30 | 5.94 | 5.92 |
2022-03-31 | 5.44 | 5.42 |
2021-12-31 | 5.57 | 5.55 |
2021-09-30 | 5.42 | 5.39 |
2021-06-30 | 5.69 | 5.65 |
2021-03-31 | 6.24 | 6.19 |
2020-12-31 | 5.15 | 5.10 |
2020-09-30 | 5.44 | 5.40 |
2020-06-30 | 5.84 | 5.81 |
2020-03-31 | 6.32 | 6.30 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | 40,612.00 | -2,341.00 | -18,540.00 |
2024-12-31 | |||
2024-09-30 | 40,368.00 | 9,566.00 | -40,988.00 |
2024-06-30 | |||
2024-03-31 | 29,539.00 | -10,045.00 | -23,327.00 |
2023-12-31 | |||
2023-09-30 | 11,717.00 | -136,031.00 | 121,051.00 |
2023-06-30 | |||
2023-03-31 | 18,525.00 | -142,818.00 | 130,487.00 |
2022-12-31 | |||
2022-09-30 | 11,543.00 | -26,775.00 | 16,327.00 |
2022-06-30 | |||
2022-03-31 | 11,766.00 | -16,991.00 | 2,421.00 |
2021-12-31 | |||
2021-09-30 | 12,763.00 | -33,708.00 | 16,862.00 |
2021-06-30 | |||
2021-03-31 | 11,597.00 | -36,247.00 | 25,640.00 |
2020-12-31 | |||
2020-09-30 | 10,484.00 | -18,213.00 | 11,437.00 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Biocon Limited pada 2025 Jun 30 adalah 41.80.
- p/libro untuk Biocon Limited pada 2025 Jun 30 adalah 1.53.
- p/tbv untuk Biocon Limited pada 2025 Jun 30 adalah -7.82.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 41.80 | 1.53 | -7.82 |
2025-03-31 | 51.38 | 1.55 | 1,497.31 |
2024-12-31 | 29.31 | 1.58 | 1,528.31 |
2024-09-30 | 27.94 | 1.75 | -31.90 |
2024-06-30 | 41.13 | 1.66 | -30.38 |
2024-03-31 | 25.67 | 1.27 | -11.43 |
2023-12-31 | 60.45 | 1.24 | -11.18 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | 60.02 | 4.51 | 5.26 |
2021-12-31 | 66.65 | 4.87 | 5.68 |
2021-09-30 | 63.75 | 5.06 | 5.89 |
2021-06-30 | 53.98 | 4.29 | 4.99 |
2021-03-31 | 49.21 | 4.28 | 4.99 |
2020-12-31 | 59.49 | 4.64 | 5.41 |
2020-09-30 | 56.34 | 4.64 | 5.41 |
2020-06-30 | 52.56 | 4.92 | 5.75 |
2020-03-31 | 48.56 | 4.92 | 5.75 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Biocon Limited pada 2025 Jun 30 adalah 0.03.
- EBIT (3 tahun) / EV untuk Biocon Limited pada 2025 Jun 30 adalah 0.03.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 0.03 | 0.03 |
2025-03-31 | 0.03 | 0.02 |
2024-12-31 | 0.04 | 0.03 |
2024-09-30 | 0.04 | 0.02 |
2024-06-30 | 0.02 | 0.02 |
2024-03-31 | 0.03 | 0.02 |
2023-12-31 | 0.02 | 0.02 |
2023-09-30 | 0.02 | 0.02 |
2023-06-30 | 0.02 | 0.02 |
2023-03-31 | 0.03 | 0.03 |
2022-12-31 | 0.03 | 0.03 |
2022-09-30 | 0.03 | 0.03 |
2022-06-30 | 0.02 | 0.03 |
2022-03-31 | 0.02 | 0.03 |
2021-12-31 | 0.02 | 0.02 |
2021-09-30 | 0.02 | 0.02 |
2021-06-30 | 0.02 | 0.03 |
2021-03-31 | 0.03 | 0.03 |
2020-12-31 | 0.02 | 0.03 |
2020-09-30 | 0.03 | 0.03 |
2020-06-30 | 0.03 | 0.03 |
2020-03-31 | 0.03 | 0.03 |
Efektivitas Manajemen
- roa untuk Biocon Limited pada 2025 Jun 30 adalah 0.02.
- roe untuk Biocon Limited pada 2025 Jun 30 adalah 0.04.
- roic untuk Biocon Limited pada 2025 Jun 30 adalah 0.02.
- croic untuk Biocon Limited pada 2025 Jun 30 adalah 0.04.
- ocroic untuk Biocon Limited pada 2025 Jun 30 adalah 0.09.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.02 | 0.04 | 0.02 | 0.04 | 0.09 |
2025-03-31 | 0.01 | 0.03 | 0.02 | 0.02 | 0.09 |
2024-12-31 | 0.03 | 0.03 | 0.03 | 0.02 | 0.09 |
2024-09-30 | 0.03 | 0.07 | 0.04 | -0.01 | 0.07 |
2024-06-30 | 0.02 | 0.05 | 0.02 | -0.01 | 0.07 |
2024-03-31 | 0.05 | 0.11 | 0.03 | -0.01 | 0.03 |
2023-12-31 | 0.02 | 0.05 | 0.01 | -0.01 | 0.03 |
2023-09-30 | 0.02 | 0.04 | 0.01 | 0.00 | 0.00 |
2023-06-30 | 0.02 | 0.04 | 0.01 | 0.01 | 0.04 |
2023-03-31 | 0.02 | 0.05 | 0.02 | 0.02 | 0.07 |
2022-12-31 | 0.03 | 0.07 | 0.04 | 0.01 | 0.07 |
2022-09-30 | 0.04 | 0.08 | 0.04 | 0.01 | 0.07 |
2022-06-30 | 0.04 | 0.08 | 0.05 | -0.02 | 0.08 |
2022-03-31 | 0.04 | 0.08 | 0.05 | -0.02 | 0.08 |
2021-12-31 | 0.04 | 0.08 | 0.05 | -0.03 | 0.09 |
2021-09-30 | 0.04 | 0.08 | 0.05 | -0.03 | 0.00 |
2021-06-30 | 0.05 | 0.09 | 0.05 | 0.01 | 0.09 |
2021-03-31 | 0.05 | 0.10 | 0.06 | 0.01 | 0.10 |
2020-12-31 | 0.05 | 0.09 | 0.06 | 0.04 | 0.10 |
2020-09-30 | 0.05 | 0.09 | 0.06 | 0.03 | 0.09 |
2020-06-30 | 0.06 | 0.10 | 0.07 | 0.02 | 0.13 |
2020-03-31 | 0.06 | 0.11 | 0.09 | 0.02 | 0.15 |
Gross Margins
- marjin kotor untuk Biocon Limited pada 2025 Jun 30 adalah 0.66.
- marjin bersih untuk Biocon Limited pada 2025 Jun 30 adalah 0.07.
- marjin operasi untuk Biocon Limited pada 2025 Jun 30 adalah 0.10.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.66 | 0.07 | 0.10 |
2025-03-31 | 0.61 | 0.05 | 0.09 |
2024-12-31 | 0.62 | 0.10 | 0.11 |
2024-09-30 | 0.62 | 0.11 | 0.11 |
2024-06-30 | 0.67 | 0.07 | 0.12 |
2024-03-31 | 0.63 | 0.08 | 0.14 |
2023-12-31 | 0.63 | 0.04 | 0.14 |
2023-09-30 | 0.62 | 0.03 | 0.14 |
2023-06-30 | 0.68 | 0.03 | 0.14 |
2023-03-31 | 0.67 | 0.04 | 0.12 |
2022-12-31 | 0.67 | 0.07 | 0.13 |
2022-09-30 | 0.67 | 0.07 | 0.13 |
2022-06-30 | 0.67 | 0.08 | 0.13 |
2022-03-31 | 0.62 | 0.08 | 0.14 |
2021-12-31 | 0.63 | 0.09 | 0.14 |
2021-09-30 | 0.63 | 0.09 | 0.13 |
2021-06-30 | 0.63 | 0.09 | 0.13 |
2021-03-31 | 0.63 | 0.10 | 0.13 |
2020-12-31 | 0.67 | 0.09 | 0.12 |
2020-09-30 | 0.67 | 0.10 | 0.14 |
2020-06-30 | 0.63 | 0.11 | 0.15 |
2020-03-31 | 0.67 | 0.12 | 0.17 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1623118 |
Grupong Pang-industriya
SIC 8731 - Commercial Physical and Biological Research |